Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zara Sayar

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Blood Advances|May 19, 2020
High rates of venous and arterial thrombotic events in patients with POEMS syndrome: results from the UCLH (UK) POEMS RegistryZara Sayar, Anna Weatherill, Stephen Keddie, et al.
Human Fertility (Cambridge, England)|May 28, 2024
Venous thromboembolism associated with medically assisted reproduction (MAR): British fertility society policy and practice guidance for assessment and preventionNeerujah Balachandren, Srividya Seshadri, Ephia Yasmin, et al.
Thrombosis Research|March 12, 2022
Safety and efficacy of apixaban as thromboprophylaxis in myeloma patients receiving chemotherapy: A prospective cohort studyZara Sayar, Carolyn Gates, Sotirios Bristogiannis, et al.
Journal of Thrombosis and Haemostasis : JTH|June 17, 2023
Coping with setbacks as early career professionals: transforming negatives into positivesAaron F J Iding, Shrey Kohli, Sofija Dunjic Manevski, et al.
Journal of Thrombosis and Thrombolysis|June 7, 2019
What are the difficulties in conducting randomised controlled trials of thromboprophylaxis in myeloma patients and how can we address these? Lessons from apixaban versus LMWH or aspirin as thromboprophylaxis in newly diagnosed multiple myeloma (TiMM) feasibility clinical trialZara Sayar, Julia Czuprynska, Jignesh P Patel, et al.
British Journal of Neurosurgery|April 21, 2022
Pharmacological venous thromboembolism prophylaxis in elective cranial surgery: a systematic review of time of initiation, regimen and durationIan Tan, Anand S Pandit, Shivani Joshi, et al.
Journal of Thrombosis and Haemostasis : JTH|November 29, 2024
Interdisciplinarity within thrombosis and hemostasis: opportunities for early career professionals to find their nicheSarah Sewaralthahab, Zara Sayar, Shrey Kohli, et al.
British Journal of Haematology|June 16, 2021
The clinical course of COVID-19 in pregnant versus non-pregnant women requiring hospitalisation: results from the multicentre UK CA-COVID-19 studyChristina Crossette-Thambiah, Phillip Nicolson, Indika Rajakaruna, et al.
British Journal of Haematology|September 9, 2021
Clinical outcomes and the impact of prior oral anticoagulant use in patients with coronavirus disease 2019 admitted to hospitals in the UK - a multicentre observational studyDeepa J Arachchillage, Indika Rajakaruna, Zain Odho, et al.
Research and Practice in Thrombosis and Haemostasis|August 14, 2024
Rivaroxaban for stroke patients with antiphospholipid syndrome (RISAPS): protocol for a randomized controlled, phase IIb proof-of-principle trialPrabal Mittal, Rafael Gafoor, Zara Sayar, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Blood Advances|May 19, 2020
High rates of venous and arterial thrombotic events in patients with POEMS syndrome: results from the UCLH (UK) POEMS RegistryZara Sayar, Anna Weatherill, Stephen Keddie, et al.
Human Fertility (Cambridge, England)|May 28, 2024
Venous thromboembolism associated with medically assisted reproduction (MAR): British fertility society policy and practice guidance for assessment and preventionNeerujah Balachandren, Srividya Seshadri, Ephia Yasmin, et al.
Thrombosis Research|March 12, 2022
Safety and efficacy of apixaban as thromboprophylaxis in myeloma patients receiving chemotherapy: A prospective cohort studyZara Sayar, Carolyn Gates, Sotirios Bristogiannis, et al.
Journal of Thrombosis and Haemostasis : JTH|June 17, 2023
Coping with setbacks as early career professionals: transforming negatives into positivesAaron F J Iding, Shrey Kohli, Sofija Dunjic Manevski, et al.
Journal of Thrombosis and Thrombolysis|June 7, 2019
What are the difficulties in conducting randomised controlled trials of thromboprophylaxis in myeloma patients and how can we address these? Lessons from apixaban versus LMWH or aspirin as thromboprophylaxis in newly diagnosed multiple myeloma (TiMM) feasibility clinical trialZara Sayar, Julia Czuprynska, Jignesh P Patel, et al.
British Journal of Neurosurgery|April 21, 2022
Pharmacological venous thromboembolism prophylaxis in elective cranial surgery: a systematic review of time of initiation, regimen and durationIan Tan, Anand S Pandit, Shivani Joshi, et al.
Journal of Thrombosis and Haemostasis : JTH|November 29, 2024
Interdisciplinarity within thrombosis and hemostasis: opportunities for early career professionals to find their nicheSarah Sewaralthahab, Zara Sayar, Shrey Kohli, et al.
British Journal of Haematology|June 16, 2021
The clinical course of COVID-19 in pregnant versus non-pregnant women requiring hospitalisation: results from the multicentre UK CA-COVID-19 studyChristina Crossette-Thambiah, Phillip Nicolson, Indika Rajakaruna, et al.
British Journal of Haematology|September 9, 2021
Clinical outcomes and the impact of prior oral anticoagulant use in patients with coronavirus disease 2019 admitted to hospitals in the UK - a multicentre observational studyDeepa J Arachchillage, Indika Rajakaruna, Zain Odho, et al.
Research and Practice in Thrombosis and Haemostasis|August 14, 2024
Rivaroxaban for stroke patients with antiphospholipid syndrome (RISAPS): protocol for a randomized controlled, phase IIb proof-of-principle trialPrabal Mittal, Rafael Gafoor, Zara Sayar, et al.
Pageof 2